Skip to content

Telemedicine effectiveness in blood sugar control and lifestyle modification.

Effectiveness of Telemedicine and Electronic Call Reminder and health Education (TECARE trial) for Diabetes : A Randomized Control Trial - TECARE

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064346
Enrollment
200
Registered
2024-03-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E089- Diabetes mellitus due to underlying condition without complications

Interventions

Intervention1: Telemedicine Support: Integrated Voice Response System and teleconsulation Control Intervention1: Regular follow up: Regular visit the diabetic clinic at regular intervals of 3 months

Sponsors

ICMR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The inclusion criteria are as follows : 1. Age group between 30 to 65 years, both sexes. 2. Patients who have personal mobile phones 3. Patients who speak and understand either English/ Regional (Tamil) language

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating women 2. Patients who are involved in any wellness programs 3. Patients with history of heart diseases 4. Patients with any orthopedic conditions that restrict physical activity 5. Patients with hearing difficulties such as hard of hearing 6. Patients with difficulties in vision

Design outcomes

Primary

MeasureTime frame
The primary outcome measure of the study is decrease in HbA1cTimepoint: The primary outcome will be measured at baseline,6 months, 9 months and at 12 months.

Secondary

MeasureTime frame
. The secondary outcomes are adherence to the drug and medication advice, adherence to dietary advice, and adherence to physical activity advice.Timepoint: at the end of 12th month

Countries

India

Contacts

Public ContactVinoth Gnana Chellaiyan Devanbu

Chettinad Hospital and Research Institute

drchellaiyan@gmail.com09944894554

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026